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Abstract
Adverse health effects of air pollution attributed mainly to airborne particulate matter have been well documented in the
last couple of decades. Short term exposure, referring to a few hours exposure, to high ambient PM10 concentration is
linked to increased hospitalization rates for cardiovascular events, typically 24 h after air pollution peaks. Particulate matter
exposure is related to pulmonary and cardiovascular diseases, with increased oxidative stress and inflammatory status.
Previously, we have demonstrated that repeated intratracheal instillation of PM10sum in BALB/c mice leads to respiratory
tract inflammation, creating in lung a condition which could potentially evolve in a systemic toxic reaction. Additionally,
plasma membrane and tissue lipids are easily affected by oxidative stress and directly correlated with inflammatory
products. With this aim, in the present investigation using the same model, we analyzed the toxic potential of PM10sum
exposure on lipid plasma membrane composition, lipid peroxidation and the mechanisms of cells protection in multiple
organs such as lung, heart, liver and brain. Obtained results indicated that PM10 exposure led to lung lipid reshaping, in
particular phospholipid and cholesterol content increases; concomitantly, the generation of oxidative stress caused lipid
peroxidation. In liver we found significant changes in lipid content, mainly due to an increase of phosphatidylcholine, and in
total fatty acid composition with a more pronounced level of docosahexaenoic acid; these changes were statistically
correlated to lung molecular markers. Heart and brain were similarly affected; heart was significantly enriched in
triglycerides in half of the PM10sum treated mice. These results demonstrated a direct involvement of PM10sum in affecting
lipid metabolism and oxidative stress in peripheral tissues that might be related to the serious systemic air-pollution effects
on human health.
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Introduction
Recent epidemiological studies indicated how air pollution
becomes a relevant factor in the occurrence of cardiovascular
diseases, demonstrating an association between both long-term
and short-term air pollution exposure and cardiovascular
morbidity and mortality events [1,2]. Short-term exposure,
referring to a few hours exposure, to high ambient PM10 (particles
#10 mm in aerodynamic diameter, comprising coarse, fine and
ultrafine particles) concentration is linked to higher hospitalization
rates for cardiovascular events [2], typically 24 h after air pollution
peaks [1].
Compelling evidences indicated that PM10 causes the most
serious effects on human health because of the broad range of
different toxic substances that particles contain [2,3]. Coarse
particles can contain biogenic materials, such as pollen, endotoxin
and spores [4]; in particular, Gram-negative bacteria were mainly
found in PM10sum, while Gram-positive bacteria were predom-
inant in PM10win [5], thus the LPS amount was greater in
PM10sum (60, 5 EU/mg) than in PM10win (20, 7 EU/mg) [6].
Also transition metals and endotoxins are potential mediators of
PM10 adverse effects, causing reactive oxygen species and
inflammatory mediator production [7,8].
It has been proved that lung inflammation plays a key role in
enhancing the extra-pulmonary translocation of smallest particles,
as confirmed by the evidence that particle translocation is
markedly increased following LPS treatment [9]. Moreover,
ultrafine particles (UFPs #0.1 mm) are able to over-pass the lung
clearance process and enter into the alveolar epithelium [10,11],
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thus increase the possibility of their translocation through the
alveolar blood barrier (ABB) [12,13] and involving UFPs in
cardiopulmonary diseases [14] and induction of neuroinflamma-
tion [15,16].
Furthermore, it must be taken into account the release into
bloodstream of pro-oxidative and pro-inflammatory mediators
produced in lung exposed to PM; these mediators are also
responsible for adverse systemic effects [3,17,18].
Systemic adverse effects could be induced by numerous
chemical species adsorbed onto particles, such as soluble metals
or polycyclic aromatic hydrocarbons (PAHs) [19,20,21].
Because PM-associated water-soluble metals can be leached off
in the lung lining fluid, they are likely to be translocated to the
pulmonary vasculature, heart, and other extra-pulmonary organs
before dilution in the systemic circulation and clearance by liver
[22]. Due to the large surface area, UFPs are able to absorb large
amounts of organic molecules compared to larger particles.
Ambient air particles demonstrated that UFPs have a higher
percentage of both elemental and organic carbon as well as PAHs
so contributing to the generation of reactive oxygen species and
oxidative stress in macrophages and epithelial cells [23].
Consistent with these assumptions, in a previous work [24] we
recently determined that repeated intratracheal instillation of
PM10sum in BALB/c mice leads to the induction of inflammation
in the respiratory tract, creating in lung a condition which could
potentially evolve in a systemic toxic reaction. Indeed, after
PM10sum intratracheal instillation, we demonstrated an increase
in inflammatory and coagulation markers in blood and heart
tissue, and a concomitant increase in markers of brain blood
barrier (BBB) damage as well as oxidative stress in brain
parenchyma [24].
Definitely, PM reach in endotoxin could trigger a local
inflammatory response in the lung, allowing the translocation of
smallest particles as well as of mediators across the ABB into
bloodstream and then causing systemic toxicity. Moreover, it is
likely that, after translocation of smallest particles, both their
organic and metal components can result in systemic oxidative
stress [25,26].
A consequence of oxidative stress is membrane lipid peroxida-
tion, primarily involving polyunsaturated fatty acids. Lipid
peroxidation generates a constellation of products among which
are reactive electrophiles such as epoxides and aldehydes [27,28].
There is increasing evidence that aldehydes are involved in many
pathophysiologic effects associated with oxidative stress in cells and
tissues [26]. Malondialdehyde is a major product of lipid
peroxidation, able to react with nucleic acid bases at physiological
pH to form adducts resulting mutagenic in mammalian cells [29]
and carcinogenic cells [30].
At last, a significant topic poorly investigated is the possible toxic
effects of PM10 on the cell membranes; in particular, the PM10
could mediate reshaping of phospholipid pattern and their fatty
acid composition. Lipids alter the geometric properties of
membranes, interface between the cellular and the extracellular
microenvironment being involved in the signalling process in
response to exogenous stimuli. Cell membrane controls protein
traffic and provides messenger molecules that mediate cell-cell
communication, suggesting that advances in our understanding of
lipid modifications induced by PM could better disclose PM
adverse effects at a molecular level.
Using an in vitro model, Brandenberger et al. [31] demon-
strated that particle exposure induces an increase in plasma
membrane surface area which correlates with the total particle
surface area that cells are exposed to. This increase may be
explained by lipid trafficking to the apical plasma membrane and
may be interpreted as a protective reaction of the cells against
particle induced stress. In according, Beretta et al. [32] found an
increase in phospholipid phosphorous in alveolar cells exposed to
organic extract of tire debris, in a dose dependent manner, but
minor differences in the phospholipid composition.
Starting from these considerations, in the present investigation
the toxic potential of PM10sum on lipid plasma membrane
composition, lipid peroxidation and the mechanisms of cell
protection have been analysed in multiple organs such as lung,
heart, liver and brain of PM10sum exposed BALB/c mice.
In particular, we measured in these organs lipid and fatty acid
content and composition, the lipid oxidation as well as heme
oxygenase-1 (HO-1) and cytochrome 1B1 (Cyp1B1) protein levels,
after the last of three intratracheal instillations of PM10sum. The
activation of HO-1 appears to be an endogenous defensive
mechanism used by cells to reduce inflammation and tissue
damage in injury models, while Cyp1B1 is involved in the
activation of many xenobiotic as well as PAHs metabolism.
Moreover the mRNA levels of Cyp1B1, HMOX, IL-1b, MIP2,
MPO, miR-21 and miR-155 were measured as inflammation
markers in lung and blood. Blood and lung parameters were
correlated to heart, liver and brain lipid changes resulting in
interesting findings.
Materials and Methods
Animals
Male BALB/c mice (7–8 weeks old) were purchased from
Harlan; food and water were administered ad libitum. Mice were
housed in plastic cages under controlled environmental conditions
(temperature 19–21uC, humidity 40–70%, lights on 7 a.m.–7
p.m.). Animal use and care procedures were approved by the
Institutional Animal Care and Use Committee of the University of
Milano Bicocca and complied with guidelines set by Italian
Ministry of Health (DL 116/92); invasive procedures have been
performed under anaesthesia and all efforts were made to
minimize suffering.
PM sources and characterization
Atmospheric PM10sum was collected during summer 2008 in a
Milan urban area as described in previous paper [33]. The
chemical characterization of PM10 collected during summer 2008
doesn’t differ from these of PM10 collected in summer 2006 and
2007 [6]. The procedure of particles recovering is fully described
in [24].
Intratracheal PM10sum instillation
Animal testing was carried out by intratracheally instilling 6
mice for each experimental group. Briefly, BALB/c mice were
anaesthetised with a mixture of 2.5% isoflurane (Flurane) and kept
under anaesthesia for all the durance of the instillation procedure.
Intratracheal instillation with 100 mg of PM10sum in 100 ml of
isotonic saline solution or 100 ml of isotonic saline solution (sham)
has been performed by means of MicroSprayer Aerosolizer system
(MicroSprayer Aerosolizer- Model IA–1C and FMJ-250 High
Pressure Syringe, Penn Century, USA), as described [34,35,36].
The intratracheal instillation was performed on days 0, 3, and 6;
24 h after the last instillation, mice from each experimental group
were euthanized with an anaesthetic mixture overdose (Tileta-
mine/Zolazepam-Xylazine and isoflurane). Experimental doses
and time course have been established in according to [24].
PM10 Affect Tissue Lipid Metabolism in Mice
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Histological analysis
Lung, Heart, Brain and Liver from sham and PM10sum-treated
mice were excised and immediately formalin fixed and processed
for histology as previously described [24].
Samples were qualitatively screened by means of Zeiss Axioplan
microscope equiped with 40x magnification and images were
acquired using Zeiss AxioCam MRc5 digital camera interfaced
with the Axiovision Real 4.6 software.
Lung, liver, brain and heart parenchyma protein analysis
Lung, liver, brain and heart of sham and PM10sum-treated
mice were quickly excised and washed in ice-cold isotonic saline
solution. For the detection and quantification of proteins, organs
were minced at 4uC, suspended in NaCl 0.9%, briefly homoge-
nized for 30 seconds at 11000 rpm with Ultra-Turrax T25 basic
(IKA WERKE) and sonicated for 30 seconds. Samples were
submitted to trichloroacetic acid (TCA) precipitation according to
the procedure described by Farina et al. [36]. The pellets were
suspended in water and protein quantity determined by BCA
method (Sigma Aldrich, USA).
Thereafter, lung, liver, brain and heart homogenates of sham
and PM10sum-treated mice were loaded on SDS-PAGE and
submitted to electrophoresis, followed by Western blot, according
to procedures described already described [36]. Homogenates
were tested with specific antibodies for HO-1 (sc-10789, Santa
Cruz) and Cyp1B1 (sc-32882, Santa Cruz). Then, blots were
incubated for 1.5 h with horseradish peroxidase-conjugated anti-
rabbit IgG (1:5000, Pierce) diluted in PBS-Tween20/milk.
Proteins were detected by ECL using the SuperSignal detection
kit (Pierce, Rockford, IL). Immunoblot bands were analysed and
the optical density (OD) quantified by KODAK (Kodak Image
Station 2000R); all the data have been normalized to b-actin
(A2066, 1:1500, Sigma) and each protein in PM10-treated group
has been normalized to the respective sham group.
Lung and blood molecular analyses
Lung and blood from 5 sham and 5 PM10sum-treated mice
were considered for RNA analysis. Lung were suspended in an
appropriate volume of RNA Later; total RNA extraction of lung
and blood was performed as previously described [24]. RNA
quality was checked by microcapillary electrophoresis with 2100
BioAnalyzer (Agilent Technologies, Santa Clara, CA, USA). Total
RNA integrity was assessed on the basis of the RIN (RNA Integrity
Number) factor and presence of low molecular weight RNA
molecules (including 5S rRNA and small RNAs) was verified.
RNA samples were stored at 280uC until use.
Quantitative PCR (QPCR) reactions for microRNAs was
performed by use of TaqMan MicroRNA Reverse Transcription
(RT) kit (Applied Biosystems, Life Technologies, Inc. Carlsbad,
CA, USA) and of specific miRNA primers provided with TaqMan
microRNA assays, according to the manufacturer’s protocol.
Starting from 10 ng of total RNA for each assay, RT reactions
were performed by means of Applied Biosystems 7900 Thermo-
cycler machine. Quantitative microRNA expression analysis was
carried out for miR-21 (Assay ID, 000397, Applied Biosystems)
normalized against U6snRNA (Assay ID, 001973, Applied
Biosystems) taken as endogenous control. For gene expression
analysis, we performed QPCR starting from 1 mg of total RNA
using the High Capacity cDNA Reverse Transcription kit (Applied
Biosystems) and gene-specific primers provided with TaqMan
Gene Expression Assays. Specifically, QPCR analysis were carried
out for HMOX1 (Assay ID Mm00516005_m1), Cyp1B1 (Assay
ID Mm00487229_m1), IL-1b (Assay ID Mm01336189_m1), MIP-
2 (Assay ID Mm00436450_m1) and MPO (Assay ID
Mm00447886_m1) genes. All data have been normalized versus
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Assay ID
Mm99999915_g1) gene taken as endogenous control. Reactions
were run in triplicate on the Applied Biosystems 7900 HT Fast
Real-Time PCR System machine. Delta Ct values were calculated
using the SDS software version 2.3 (Applied Biosystems), by
applying automatic baseline and standard threshold settings.
Lipid analysis
Tissues were submitted to lipid extraction with three different
chloroform/methanol mixtures 1:1, 1:2, 2:1 (v/v) and partitioned
chloroform/methanol/water, 47:48:1, v/v/v and then with water.
The organic phase, after partitioning, was dried and resuspended
in chloroform/methanol (2:1) for the analysis of phospholipid (PL),
neutral glycolipid and cholesterol amount. All solvent contained
BHT as antioxidant.
Purification and quantitative analysis of membrane phospho-
lipids and cholesterol was obtained using an HPLC-ELSD system
(Jasco, Japan; Sedex SEDERE, FR) equipped with a LiChrospher
Si 60 column (LiChroCART 250-4, Merck, Darmstadt, Ger-
many).
The chromatographic separation was carried out as previously
described [37]. By means of Evaporative Light Scattering Detector
(ELSD) we detected and quantified separated PL species. After
elution, samples were splitted in two aliquots. The ratio was 1:9,
i.e. one part to the detector and nine parts have been collected by
Gilson Fraction Collector Model 201, in order to separate the
different phospholipid classes for further gas chromatographic
analysis (GC). After separation, each phospholipid class has been
analysed for fatty acid composition by GC in following conditions.
Fatty acid methyl esters were obtained by transesterification
with sodium methoxide in methanol 3.33% w/v and injected into
Agilent (Agilent Technologies 6850 Series II) gas chromatograph,
equipped with a flame ionization detector (FID) under the
following experimental conditions: capillary column: AT Silar
length 30 m, film thickness 0.25 mM. Gas carrier: helium,
temperature Injector 250uC, detector 275uC, oven 50uC for
20 min, rate of 10uC min21 until 200uC for 20 min.
Neutral glycolipids, Triglyceride and Cholesterol were separat-
ed by HP-TLC using silica gel plates (Merck, Darmstadt,
Germany). Chromatography running and quantitative analysis
was performed as previously described [38]. The delipidized pellet
was used to assay protein amount [39].
Statistical analysis
SPSS (IBM) was used as platform for statistical analysis. In
particular, means and standard deviations were initially calculated
and multiple variable two way ANOVA coupled to Bonferroni
assay to determine differences between organ lipids and molecular
markers of treated and untreated mice. Statistical differences with
a p value below 0.05 were considered significant. Related graphs
were drawn with GraphPad Prism 5. Furthermore, Pearson’s
correlations were estimated between lipid and molecular quanti-
tative parameters within each organ as well as between different
organs; Pearson’s correlation coefficients with a p value below 0.05
were considered significant.
For HO-1 and Cyp1B1 western blot analyses in tissues from
sham and PM10sum experimental groups, results have been
expressed as mean 6 standard error (s.e.). Data distribution was
tested by Shapiro-Wilk test; statistical differences were tested
accordingly by non-parametric U Mann-Whitney test. Statistical
differences were considered to be significant at the 95% level (p
value ,0.05).
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Results
Lung, heart, liver and brain parenchyma histology and
lipid analysis
Lung and heart histological analyses are shown in Figure 1.
Panels A and B report analyses from sham and PM10sum-treated
mice lung respectively. No signs of particle accumulation signs
were determined in lungs; nevertheless, it was possible to observe
inflammatory cell recruitment and alveolar macrophage infiltra-
tion (arrows) in the connective surrounding terminal bronchioles
and proximal alveolar sacs (panel B). Panels C and D report heart
histological images; no clear sign of tissue steatosis or inflammation
was evident in the heart parenchyma. Finally in brain and liver of
treated mice the histological analysis did not show any difference
in comparison to the organs of sham mice (data not shown); no
evidence of reactive gliosis nor cortical laminar hyperintensities
within the neocortex and subcortical white matters was evident in
PM10sum treated mice.
Data of protein, DNA, and lipid subclass amount in different
tissues obtained from sham or PM10sum-treated mice are
represented in Figure 2 as changes relative to mean sham. Table
S1 reports the actual mean amounts of the measured parameters
and the related statistical analysis, while Table S2 reports the
Pearson’s correlation coefficients between lipid and molecular
parameters within each organ.
Obtained results showed that PM10sum exposure led to an
increase in protein amount in all tissues, significantly higher in
lung, brain and heart comparing to sham. As expected, the
phospholipid amount significantly increased in lung after
PM10sum exposure and, surprisingly, this increase was recorded
also in liver. Cholesterol was increased in lung, while the quantity
of neutral glycosphingolipids was significantly increased in the
heart. The analysis of specific lipid classes and correlation
statistical tests led to conclude that the phospholipid increase
was related mainly to phosphatidylcholine (PC) in lung (r = 0.925
p,0.01), while in liver was strictly correlated with both
phosphatidylethanolamine (PE) and PC (r = 0.856 and r = 0.963).
Worth of note is that in lung the increase of PC was statistically
correlated with cholesterol increase (r = 0.942, p,0.01).
Sphingomyelin significantly increased in lung and liver while a
significant decrease was measured in brain. The tiobarbituric
reactive substances (TBARS) levels were measured as lipid
oxidation index. This value is significantly increased only in the
lung of PM10sum-treated mice.
In Figure 3 we reported changes relative to mean sham of total
fatty acids composition in different tissues; percentage fatty acid
composition and related statistical analysis are reported in Table
Figure 1. Histology of lung and heart tissue of sham (A, C) and PM10sum-treated (B, D) mice, 24 h after the third intratracheal
instillation. Each figure represents the status evidenced examining 6 sham and 6 PM10sum-treated mice. A and B bars = 50 mm. C and D bars
= 25 mm. Lung results modified from Farina et al., 2013 [24].
doi:10.1371/journal.pone.0106855.g001
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S1. No significant differences were found in total fatty acid
composition of lung from PM10sum-treated mice, comparing to
sham, even if the content of C22:5 was directly correlated with
TBARS (r = 0.86, p,0.05) while omega-6/omega-3 ratio was
inversely correlated with it (r =20.845, p,0.05, Table S2).
Conversely, the other tissues showed significant changes in fatty
acid composition after PM10sum exposure. In particular, in both
liver and brain monounsaturated fatty acids decreased, concom-
itantly, omega-3 and polyunsaturated fatty acids, in particular
docosahexaenoic acid (DHA), increased. In liver, a significant
increase of arachidonic acid (AA) was also determined.
HPLTC analysis of neutral lipids, containing cholesterol and
triglycerides (TAG), underlined in 3 out of 6 PM10sum-treated
mice a significantly higher amount of triglycerides (Fig. S1,
Table 1) compared to sham. The level of TAG significantly
correlates in heart with the fatty acid composition (Table S2). For
this reason, we divided into 2 groups the PM10sum-treated mice
hearts: group A with a slight increase of triglyceride amount, and
group B with a high and significant increase of triglycerides. Major
changes in total fatty acid composition were present in hearts from
group B; in fact, due to the high TAG component, the fatty acid
composition was significantly modified, with an increase of
monounsaturated fatty acids and a parallel decrease of omega-3
polyunsaturated fatty acids (PUFAs), in particular DHA. More-
over, a slight decrease of AA was also measured (Table 1).
Fatty acid composition analysis followed HPLC separation of
each phospholipid class from lipid extracts. Brain and liver results
are summarized in supplemental tables (Tables S3–S4), while we
focused our attention on lung and heart phospholipid fatty acid
composition. Concerning lung, PE showed an increase of AA
while phosphatidylserine (PS) fatty acid composition was charac-
terized by significant changes in the major fatty acids resulting in
an increased n-6/n-3 ratio (Table 2). Conversely, all the other
tissues were characterized by an increase of DHA. This increase
was particular evident in all the phospholipids extracted from
heart, but sphingomyelin (SM) (Table 3). In brain (Table S3) PS
Figure 2. Protein, DNA, and lipid subclass changes in lung, liver, heart and brain of PM10sum-treated mice. Data were calculated as
percentage variation relative to mean sham value. Statistical analysis was performed on actual amounts by a two way ANOVA coupled to Bonferroni’s
test. n = 6 for PM10sum and n= 5 for Sham mice. * = p,0.05. Mean data and statistical results reported in Table S1.
doi:10.1371/journal.pone.0106855.g002
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and SM were the major affected phospholipids, while in the liver
(Table S4) the increase of DHA was recorded only in PC.
Lung, heart, liver and brain parenchyma protein analysis
A significant increase in HO-1 level, a protein involved in
inflammation and oxidative stress, was observed in lung and brain
of PM10sum-treated mice, comparing to sham; on the contrary, in
heart and liver HO-1 showed no significant variation (Fig. 4).
The level of Cyp1B1, a cytochrome of the P450 superfamily
involved in the activation of many xenobiotic as well as in PAHs
metabolism, significantly decreased in treated mice lung 24 h after
PM10sum intratracheal instillation, while a significantly increase
was observed in heart of treated mice, comparing to respective
sham. In liver and brain, Cyp1B1 showed no significant variation
(Fig. 4).
Moreover, as previously reported, many other inflammation/
stress proteins were significantly increased in lung, heart, brain
and inflammatory cells were present in blood and bronco alveolar
lavage fluid (BALF) of PM10sum treated mice. In particular we
previously recorded an increase of AMs and PMNs cells, mainly
neutrophils, in BALF and blood of PM10sum treated mice [24].
RNA expression in lung and blood: correlations with
lipids
To follow inflammation markers, in both blood and lung the
gene expression of different markers were measured. HO-1
(HMOX) acts as defense protein and its deficiency leads to
enhanced endothelial cells injury [40]. HO-1 role is to catabolize
the heme group from the cytosol, thus generating CO, biliverdin
Figure 3. Fatty acid composition changes in lung, liver, heart and brain of PM10sum-treated mice. Data were calculated as percentage
variation relative to mean sham value. U.I. = Unsaturation Index (sum of the % unsaturated fatty acids multiplied by their number of double bonds).
Statistical analysis was performed on percentage fatty acid distribution by two way ANOVA coupled to Bonferroni’s test. n = 6 for PM10sum and n=5
for Sham mice. * = p,0.05. Mean data and statistical results reported in Table S1.
doi:10.1371/journal.pone.0106855.g003
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(converted to bilirubin) and Fe2+ thus playing a protective role
against inflammation and oxidative stress [41].
One of the major markers of inflammation is TNFa, a
pleiotropic cytokine [42], able to induce the release of other
factors such as MIP-2 (IL-8 in humans, MIP-2 in rodents) and
IL1b [43]. In mice the C-X-C chemokine macrophage inflam-
matory protein MIP-2 has been identified as chemoattractant of
neutrophils in vitro and in vivo [44]. Interleukin-1b is a master
cytokine, known to be involved in initiating the innate immune
response in vertebrates and in cytokines expression [45,46].
MPO is an inflammatory marker released by degranulation of
activated neutrophils promoted by IL-1b [47].
The miR-21 is involved in negative regulation of the signaling
pathway of TLR-2 [48] and TLR-4 [49], thus playing a key role in
inflammatory process induced by LPS. Moschos et al. [50] and
Sheedy et al. [49] hypothesized that miR-21 might be involved in
the resolution rather than in the induction of inflammation.
Finally miR-155 is involved in the HMGB1/RAGE signaling
pathway, whose activation lead to the enhanced expression of
cytokines and molecules; thought it plays a role in particle effects,
including the release of proinflammatory cytokines (such as tumor
necrosis factor alpha, interleukin IL-1b, IL-6 and IL-8), adhesion
molecules (i.e. vascular cell adhesion molecule 1 and intercellular
adhesion molecule 1), and coagulation factors (i.e. plasminogen
activator inhibitor-1, tissue-type plasminogen activator and tissue
factor) [51–54].
Gene expression results are reported in Figure 5; data were
normalized to housekeeping genes and reported as dCT. A
significant increase of MIP2 and miR21 was recorded as
inflammatory gene expression in lung, while no statistical
differences were observed in blood.
Correlation analysis between blood and lung molecular and
lipidic parameters coupled to heart, liver and brain data revealed
interesting observations. Obtained results are actually reported in
Figure 6 as a simplified heath matrix.
As observable, inflammation markers measured in blood and
level of proteins in lung highly correlated with tissue lipid
composition in heart. Moreover, the level of AA and gene
expression in lung were directly correlated with liver phospholip-
ids.
Also brain lipids were significantly influenced by lung param-
eters, in particular, the levels of omega-6 and omega-3 polyun-
saturated fatty acids.
Discussion
Epidemiological and experimental studies demonstrated posi-
tive associations between adverse cardiopulmonary effects and
acute and chronic exposure to concentrations of ambient air
pollution currently found in major metropolitan areas [17].
The connection between exposure to PM and harmful
cardiopulmonary effects has been reasonably well established,
while the evidence that the central neuronal system (CNS) may be
another PM target is growing. Indeed, PM might be associated
with cerebrovascular and neurodegenerative diseases [55].
It is known that PM10 exposure increases plasma ET-1 levels
[56], thus mediating systemic endothelial dysfunction. We
demonstrated also PM10sum toxicity on cardiovascular system
Table 1. Triglyceride (TAG) content and total fatty acid composition (%) of Heart from Sham and PM10sum treated mice. PM10
mice were divided into 2 groups: A) with low content of Triglycerides and B) with high content of Triglycerides.
HEART
Fatty Acid Sham PM10-A PM10-B
C16:0 14.1160.83 15.4862.08 20.2361.69*
C16:1 0.5860.46 0.6760.27 2.4161.42*
C18:0 19.8461.45 18.2660.33* 11.7861.45*
C18:1 7.2960.59 8.2462.06 23.4864.05*
C18:2 15.4561.54 15.5760.91 21.4161.62*
C20:3 0.6860.06 0.9360.51 0.5560.15*
C20:4 7.8660.45 7.2160.77 4.3461.02*
C20:5 0.1860.06 0.1860.07 0.1060.03*
C22:5 1.5360.19 1.5560.14 0.7960.25*
C22:6 32.2862.36 31.6160.64 14.5765.29*
Saturated F.A. 33.9562.04 33.7462.33 32.0160.71
Monounsaturated F.A. 7.8760.87 8.9162.06 25.886 5.17*
C18:0/C18:1 2.7460.31 2.3460.59 0.5260.15*
Omega-3 PUFAs 34.2662.43 33.7063.15 15.8465.56*
Omega-6 PUFAs 23.9961.94 23.7061.25 26.2960.66*
v-6/v-3 0.7160.09 0.7160.06 1.8560.74*
U.I. 275.09613.08 270.90619.26 180.07629.06**
TAG (mg/mg w.w.) 2.3961.79 3.9162.45 38.39610.08**
U.I. = Unsaturation Index (sum of the % unsaturated fatty acids multiplied by their number of double bonds).
Mean 6 S.D.
*p,0.05;
**p,0.01 vs. Sham.
doi:10.1371/journal.pone.0106855.t001
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and brain parenchyma after PM10sum instillation, thus confirm-
ing PM systemic effects [24].
Several mechanisms have been proposed to explain the adverse
health effects of particulate pollutants. These include inflamma-
tion, endotoxin effects, stimulation of capsaicin/irritant receptors,
autonomic nervous system activity, pro-coagulant effects, covalent
modification of cellular components and ROS production. Among
these, ROS production and the generation of oxidative stress have
Figure 4. mRNA levels of Cyp1B1, HMOX, IL1b, MIP2, MPO, miR-21 and miR-155 in lung and blood. Data were normalized to
housekeeping gene and expressed as delta CT; values greater or equal to 17 indicates no detectable gene expression. n = 5, * = p,0.05.
doi:10.1371/journal.pone.0106855.g004
Figure 5. Immunoblotting analysis in lung, liver, brain and heart parenchyma from sham and PM10sum-treated mice, 24 h after the
third intratracheal instillation. (A) Western blot analysis of HO-1, Cyp1B1 as optical density (OD) quantified by Kodak Image Station. The proteins
have been normalized to b-actin and each protein in PM10 treated group has been normalized onto respective sham group. (B) Representative
Western blotting showing HO-1, Cyp1B1 and b-actin in lung, liver, brain and heart parenchyma from sham and PM10sum-treated mice, 24 h after the
third intratracheal instillation. All the data are expressed as mean 6 S.E. Sham vs. PM10sum-treated: * = p,0.05.
doi:10.1371/journal.pone.0106855.g005
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received the most attention [57]. Ambient particles contain a large
number of soluble metals including transition metals that are
capable of redox cycling. Evidence is also accumulating to suggest
that organic components carried on the particle surface play an
important role in mediating the toxic effect. For example, PAHs
can induce oxidative stress indirectly, through biotransformation
by cytochrome P450 to generate redox active quinones that act as
catalysts for free radical production [58].
Here, we investigated lipid variations induced in lung paren-
chyma after PM10sum intratracheal instillation in BALB/c mice;
in parallel, we analyzed HO-1 and Cyp1b1 levels. Extra-
pulmonary tissues were also affected by PM10sum exposure; we
were able to measure significantly changes in lipids amount and
protein levels in liver, brain and heart strictly correlated to lung
and blood parameters.
Lung
Lipid modification of lung tissue and surfactant are well
described as primary effects of different particulate matter in
humans and animal models [59,60], while there are scattered data
on other tissue lipid modifications.
As previously described, we found in lung the histological
features and the increase of proteins and lipids related to the
inflammatory process together with the increase of surfactant
stored in type II cells [61]. It seems also important to notice that
the increase of PC, strictly correlated with liver phospholipids,
could be also related to an anti-inflammatory protection system, as
some studies have demonstrated this potential for PC and its
metabolites in various conditions such as oxidative stress and
endotoxin induced injuries [62].
Regarding the increase of cholesterol content, this alteration is
already described by electron microscopy in the lung of heavy
cigarette smokers and it has been hypothesized that cholesterol
may represent a degenerative change in type II pneumocytes [63].
The PM triggers pulmonary oxidative stress and inflammation
by means of heterogeneous and complex mechanisms, with
variable responses according to different properties of PM particles
(e.g. size, charge, chemistry). Our previous work demonstrated the
presence of inflammation, oxidative stress and endothelial
activation in lung of PM10sum-treated mice [24]. Lung oxidative
stress has been confirmed in the current work, by increase of
TBARS and HO-1 levels in PM10sum-treated mice. Consequent
to HO-1 increase, the lung parenchyma of PM10sum-treated mice
showed a decrease in Cyp1B1 levels, due to reduced heme group
bioavailability [64]. Even if the increase of TBARS indicates that
lipid peroxidation might be occurred, with our protocol of
exposure we did not find changes of total fatty acid composition
[65]. On the contrary, when single phospholipid fatty acid
composition was evaluated, we measured a significant increase
of AA in PE and changes in n-6/n-3 fatty acid ratio, indicating in
PI, PS and PC; the decrease of n-3 fatty acids might be related to
TBARS increase in treated mice. It is known that the n-6/n-3 fatty
acid ratio in alveolar cell membranes regulates pro-inflammatory
cytokine release, as n-3 PUFAs are regarded to be anti-
inflammatory while n-6 PUFAs, and particularly AA, are pro-
inflammatory [66].
Moreover, Kampfrath [67] recently reported that chronic
exposure to ambient air-borne PM2.5 increases oxidized phos-
pholipid derivatives of 1-palmitoyl-2-arachidonyl-sn-glycero-3-
phosphoryl-choline in broncoalveolar lavage fluid.
All these results, both lipids and proteins, confirmed the
existence of inflammatory status in the lung of PM10sum treated
mice.
Liver
Liver is the major organ responsible for the detoxification of
chemical compounds and lipid metabolism. It has been suggested
that PM could reach the liver but the hepatic effects would not
necessarily depend on changes in the lung or elsewhere. Instead,
hepatic effects would arise from the direct contact of PM and
resident phagocytic hepatic cells (e.g., Kupffer cells), which are
demonstrated in in vivo exposure experiments [68]. Analyses of
HO-1 and Cyp1B1 expression showed no modification in liver of
PM10sum-treated mice comparing to sham.
Surprisingly, in liver we found significant changes in lipid
content mainly due to an increase of PC and total fatty acid
composition with a more pronounced level of unsaturated fatty
acids, in particular DHA, and an increase of unsaturation index.
The changes of lipids are statistically correlated to molecular
markers expressed in lung such as IL-1b and CYP1B1. These
results might also be related with the presence in PM10sum Milan
particulate of 2,3,7,8-tetrachlorodibenzo-p-diioxin (TCDD), even
if we did not verify its presence. TCDD in fact is able to interact
with aryl hydrocarbon receptor altering hepatic lipid metabolism;
previous results have demonstrated that TCDD is able to
significantly increase liver PUFA content [69]. These data may
represent a preliminary indication that chronic exposure might
induce metabolic liver decompensation ending in nonalcoholic
steatohepatitis (NASH) and insulin resistance [70].
Brain
Recent evidence links air pollution exposure to CNS pathology
and disease [71,72]. Even the mechanisms underlying brain
pathology, induced by air pollution, have to be clarified, there are
some evidence focused on neuroinflammation, oxidative stress,
endothelial and glial activation, and cerebrovascular damage as
possible pathways affecting the BBB [24,73,74].
In the present work, higher HO-1 levels were found in brain of
treated mice, confirming oxidative stress induced by PM10sum.
The brain is believed to be particularly vulnerable to oxidative
stress, in particular neurons, as it contains high concentrations of
PUFAs which are susceptible to lipid peroxidation, consumes
relatively large amounts of oxygen for energy production, and has
lower antioxidant defences compared to other organs [75].
Interestingly, microglia consistently generate ROS when activated
by multiple pro-inflammatory triggers, such as particles [76,77].
Oxidative stress is a common characteristic shared across
numerous neurodegenerative diseases [78–82].
Guo has demonstrated in rats that PM10 induce also brain
inflammation, and our data seem to confirm this hypothesis even if
an increase of n-3 PUFAs, in particular DHA, might indicate that
the organism is fighting inflammation producing pro-resolution
mediators [55]. In fact, the increase of omega-3 PUFAs in brain is
directly correlated with the omega-6/omega-3 ratio in lung.
Furthermore, these data are in agreement with liver results,
indicating that liver PUFAs might be transported to other tissue as
Figure 6. Correlation Heat Map Matrix between Blood and lung parameter couple with liver heart and brain data. Pearson’s
correlations were estimated using SPSS platform and transformed in a color code matrix. Only correlation with an R greater than 0.6 were coded;
positive correlation are indicated with a red scale (red indicates statistical significant ones with p,0.05 or 0.01), while negative correlation are
indicated with a blue scale (dark blue indicates statistical significant ones with p,0.05 or 0.01).
doi:10.1371/journal.pone.0106855.g006
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a refurbishment against tissue damage and inflammation.
Eicosapentaenoic acid and DHA, n-3 fatty acids, are metabolized
to resolvins and protectins, such as neuroprotectin D1, which has
important roles in resolution of inflammation [83].
Heart
During the last decade, further evidence in this direction has
progressively accumulated, so the updated AHA-2010 scientific
statement specifically defined PM exposure as ‘‘a modifiable factor
that contributes to cardiovascular morbidity and mortality’’ [84].
Indeed, it has been shown that short-term (from few hours to
weeks) exposure to PM triggers both fatal and non-fatal
cardiovascular events, while long-term exposure to the same
particles is associated with a greater reduction of life expectancy
[85,86].
Heart parenchyma of PM10sum-treated mice showed an
increase in Cyp1B1 levels as well as endothelial activation, but
no oxidative stress [24]. These results have been confirmed in the
present work: the increase in Cyp1B1 levels, which happens as
HO-1 (not significantly increased) does not consume the heme
pool, suggests a direct translocation of the PAHs component of
PM, or of smallest particles themselves, from lung to heart,
possibly through the pulmonary circulation.
Nevertheless, our data indicate that PM10sum effects lipid
composition in the heart and these changes are strictly correlated
to molecular marker expression in blood. It has been suggested
that myocardial lipid deposition, changes in lipidomic profile and
possible mitochondrial impairment as db/db models of obesity
might seriously impact cardiac function [86]. In particular, we
found, after PM10sum treatment, an increase of triglyceride
amount in 50% of mice after PM10sum treatment. The storage of
triglyceride droplets within cardiomiocytes has been already
described [87]; moreover, abnormal cytoplasmatic structures have
been noticed in cardiac muscle cells of mice exposed to air
pollution, a modification rarely noted in the sham group [88].
However, microscopy analyses did not reveal in heart parenchyma
of group B PM10sum-treated mice any signs of tissue steatosis.
Heart tissues of the group B were also characterized by a
significantly modified total fatty acid composition, with an increase
of monounsaturated fatty acids parallel, concomitantly to a
decrease of omega-3 PUFAs, in particular DHA, and a consequent
increase in n-6/n-3 ratio, that might be related to triglyceride
accumulation.
On the contrary, as in liver and brain, heart phospholipid fatty
acids were characterized by an increase of DHA also in
cardiolipin. The ability of circulating DHA to displace linolenic
acid from cardiolipin was already described [89]. The conse-
quence of these changes might be related to mitochondrial
respiration decrease and an increase of oxidative stress suscepti-
bility [89]. Despite no oxidative stress was detectable in this
experimental time window in heart parenchyma of our PM10sum-
treated mice, the significant increase in Cyp1B1 levels could
represent the first step for the upcoming start of oxidative stress
and inflammation, suggested also by n-6/n-3 ratio.
Conclusions
The association of air pollution with a number of adverse
respiratory and cardiovascular health effects has been well
documented. In fact, the impact of air pollutants on the respiratory
system has been widely and consistently reported in last years and
new epidemiological evidence which links air pollution to
mortality from lung cancer is robust [90].The general consensus
indicates that one of the mechanisms of air pollution-induced
health effects is the oxidative stress whose main target are the
lipids. By the way, membrane fatty acid composition was recently
correlated to longevity [91].
Our results demonstrate that repeated exposure of PM10sum in
BALB/c mice led to lung lipid reshaping, in particular an increase
in phospholipid and cholesterol content; concomitantly, the
generation of oxidative stress causes lipid peroxidation. The
translocation of mediators, cytokines, UFPs, LPS and/or metals
associated to PM10sum from lung to bloodstream might trigger
systemic adverse effects, involving heart, brain and liver that we
report.
In conclusion, recent epidemiological and animal toxicology
studies have raised concerns about the potential impact of air
pollution on peripheral tissues; in this contest, our results
contribute to this vision demonstrating a direct involvement of
PM10sum in affecting lipid metabolism in peripheral tissues.
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